Product Information
DOXEPIN HCL 3 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.3644 per EA under NDC 59651084430. Its NADAC has been published 44 times since Oct 22, 2025.
FDA first approved this application on Jul 25, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651084430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216041FDA Approved
7/25/2024
TE Code
AB
On Market Since
7/12/2025
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 3 MG TABLET has been published 44 times since Oct 22, 2025, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3644 per EA |
|---|---|
| All-time high | $2.1099 (Nov 12, 2025) |
| All-time low | $1.3271 (Jul 22, 2026) |
| 52-week high | $2.1099 |
| 52-week low | $1.3271 |
| Median price | $1.5861 |
| Average price | $1.6860 |
| Largest weekly change | -16.0% (Jan 21, 2026) |
| Weeks tracked | 44 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DOXEPIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.3644 per EA (NDC 59651084430), effective Aug 19, 2026.
How has the price of DOXEPIN HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 35.3%. It has been tracked across 44 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?
Since Oct 22, 2025, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3271 (Jul 22, 2026) to a high of $2.1099 (Nov 12, 2025), with a median of $1.5861 per EA.
Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN HCL 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DOXEPIN HCL 3 MG TABLET?
DOXEPIN HCL 3 MG TABLET (NDC 59651084430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.